News

REGISTRATION OPEN! WGND Annual Meeting and Dinner 2011

We invite you to join us for the Stop TB Partnership Working Group on New Drugs’ Annual Meeting 2011 at the Grand Palais in Lille, France, on October 26. Also, we are sponsoring a dinner on October 25 at Le Barbue d’Anvers in Lille to allow our Sub-groups (Biology/Targets, Candidates, Critical Knowledge and Tools, and Clinical Trial Capacity) to meet and plan for activities for 2012. Please make plans to attend both events. See details below.

You must register for the WGND DINNER and the WGND ANNUAL MEETING separately!

Event: WGND Sub-Groups Working Dinner > REGISTER

WHEN: Tuesday, October 25, 2011 19:00 to 22:00

WHERE: Le Barbue d’Anvers, 1 bis Rue St Etienne, Lille, France

DESCRIPTION: All WGND members who will be attending the events in Lille are invited to a dinner sponsored by the WGND. The dinner will be an opportunity for members of each WGND Subgroup (Biology/Targets, Candidates, Critical Knowledge and Tools, Clinical Trial Capacity) to discuss and plan for 2012 activities and provide feedback on 2011 activities. If you have not officially joined a specific subgroup, we encourage you to attend the dinner take the opportunity to see what the subgroups are doing and join in the discussions. If you would like to bring a guest/colleague, please send me an e-mail at wgnd@newtbdrugs.org

CLICK HERE TO REGISTER FOR THE SUB-GROUPS WORKING DINNER


Event: 2011 WGND Annual Meeting > REGISTER

WHEN: Wednesday, October 26, 2011 08:00 to 12:30

WHERE: EUROTOP Auditorium, Grand Palais, Lille, France

DESCRIPTION: The WGND will host our annual meeting at the start of the 42nd Union World Conference on Lung Health (The Union) in Lille, France. During the meeting we will review progress of projects in the Global TB Drug Pipeline, review WGND 2011 activities, and network. Representatives from the following organizations and companies are confirmed to speak: AstraZeneca, GlaxoSmithKline (GSK), Novartis, Pfizer, Sanofi-aventis, Sequella, Stop TB Partnership Working Group on New Diagnositcs, TB Alliance, Tibotec, Tuberculosis Trials Consortium.

CLICK HERE TO REGISTER FOR THE ANNUAL MEETING

Other Must-Attend Events at the Conference

Event: Sponsored Symposium – Synergies in the development of New Diagnostics, Drugs and Vaccines for Tuberculosis

WHEN: Friday, October 28, 2011 16:45 to 18:45

WHERE: Room Faidherbe, Grand Palais, Lille, France

CLICK HERE FOR MORE INFORMATION (.pdf download)


Event: 2011 Stop TB Partnership Working Group on New Diagnostics Annual Meeting

WHEN: Wednesday, October 26, 2011 13:30 to 17:30

WHERE: EUROTOP Auditorium, Grand Palais, Lille, France

CLICK HERE FOR MORE INFORMATION

Please do not hesitate to let me know if you experience problems with registration or have questions.

Explore. Learn. Join the Conversation at www.newtbdrugs.org.

More News
23 Aug 2022
Last week, the PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...
5 Apr 2022
On April 01, 2022, the Stop TB Partnership launched the second online consultation for the new Global Plan to End TB 2023-2030. Over the years, the Global Plans have been important tools for advocacy and resource mobilization, and served as a reference document for donors and stakeholders. In May...